Journal of Adolescent Health
Volume 47, Issue 1 , Pages 3-11 , July 2010

Human Papillomavirus Vaccination of Males: Attitudes and Perceptions of Physicians Who Vaccinate Females

  • Thomas W. Weiss, Dr.P.H.

      Affiliations

    • Global Health Outcomes, Merck & Co., Inc., West Point, Pennsylvania
    • Corresponding Author InformationAddress correspondence to: Thomas W. Weiss, Dr.P.H., Global Health Outcomes, Merck & Co., Inc. P.O. Box 4, WP97-A243, 770 Sumneytown Pike, West Point, PA 19486-0004.
  • ,
  • Gregory D. Zimet, Ph.D.

      Affiliations

    • Department of Pediatrics, Section of Adolescent Medicine, Indiana University School of Medicine, Indianapolis, Indiana
  • ,
  • Susan L. Rosenthal, Ph.D.

      Affiliations

    • Department of Pediatrics, Columbia University Medical Center, New York, New York
  • ,
  • Susan K. Brenneman, Ph.D.

      Affiliations

    • i3 Innovus, Eden Prairie, Minnesota
  • ,
  • Jonathan D. Klein, M.D.

      Affiliations

    • American Academy of Pediatrics, Elk Grove Village, Illinois
    • Department of Pediatrics, University of Rochester Medical Center, Rochester, New York

Received 2 February 2010 ,Accepted 2 March 2010.

References 

  1. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6–10
  2. Insinga RP, Liaw KL, Johnson LG, et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17:1611–1622
  3. Giuliano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26(Suppl 10):K17–K28
  4. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(Suppl 3):35–41
  5. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: Analytic framework and review of the literature. Pharmacoeconomics. 2005;23:1107–1122
  6. Food and Drug Administration. Gardasil approval letter, 2006. Available at: http://www.fda.gov/cber/approvltr/hpvmer060806L.htm. Accessed April 15, 2009.
  7. Food and Drug Administration. Cervarix approval letter, 2009. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186959.htm. Accessed October 26, 2009.
  8. ACIP. Provisional recommendations for HPV vaccine, 2009. Available at: http://www.cdc.gov/vaccines/recs/provisional/downloads/hpv-vac-dec2009-508.pdf. Accessed December 3, 2009.
  9. Food and Drug Administration. Gardasil approval letter, 2009. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186991.htm. Accessed October 19, 2009.
  10. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med. 2007;45:107–114
  11. Jain N, Euler GL, Shefer A, et al. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48:426–431
  12. Rosenthal SL, Weiss TW, Zimet GD, et al. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine, in press. Doi: 10.1016/j.vaccine. 2009.1012.1063.
  13. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. J Adolesc Health. 2009;45:453–462
  14. Liddon N, Hood J, Wynn BA, et al. Acceptability of human papillomavirus vaccine for males: A review of the literature. J Adolesc Health. 2010;46:113–123
  15. Ferris DG, Waller JL, Miller J, et al. Variables associated with human papillomavirus (HPV) vaccine acceptance by men. J Am Board Fam Med. 2009;22:34–42
  16. Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: A meta-analytic review. Br J Soc Psychol. 2001;40(Pt 4):471–499
  17. AAPOR. Standard Definitions: Final dispositions of case codes and outcome rates for surveys. Lenexa, KS: American Association for Public Opinion Research; 2006;
  18. Daley MF, Liddon N, Crane LA, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118:2280–2289
  19. Kahn JA, Rosenthal SL, Tissot AM, et al. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr. 2007;7:367–373
  20. Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005;18:391–398
  21. Kahn JA, Zimet GD, Bernstein DI, et al. Pediatricians' intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes. J Adolesc Health. 2005;37:502–510
  22. Chao C, Velicer C, Slezak JM, et al. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc. 2009;84:864–870
  23. Chao C, Velicer C, Slezak JM, et al. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010;171:357–367
  24. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:1100–1103
  25. Neubrand TP, Breitkopf CR, Rupp R, et al. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila). 2009;48:966–969
  26. U.S. Teen Sexual Activity. 2005. Available at: http://www.kff.org/youthhivstds/upload/U-S-Teen-Sexual-Activity-Fact-Sheet.pdf. Accessed February 23, 2010
  27. Hoy T, Singhal PK, Willey VJ, et al. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin. 2009;25:2343–2351
  28. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle. Int J STD AIDS. 1998;9:571–578
  29. Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol. 2007;107(2 Suppl. 1):S24–S26
  30. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13:28–41
  31. Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health. 2008;57:23–32
  32. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis. 2009;36:58–62
  33. Ferris DG, Waller JL, Miller J, et al. Men's attitudes toward receiving the human papillomavirus vaccine. J Low Genit Tract Dis. 2008;12:276–281
  34. Tissot AM, Zimet GD, Rosenthal SL, et al. Effective strategies for HPV vaccine delivery: The views of pediatricians. J Adolesc Health. 2007;41:119–125
  35. Watts LA, Joseph N, Wallace M, et al. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol. 2009;112:577–582
  36. Lenehan JG, Leonard KC, Nandra S, et al. Women's knowledge, attitudes, and intentions concerning human papillomavirus vaccination: Findings of a waiting room survey of obstetrics-gynaecology outpatients. J Obstet Gynaecol Can. 2008;30:489–499
  37. Ogilvie GS, Remple VP, Marra F, et al. Intention of parents to have male children vaccinated with the human papillomavirus vaccine. Sex Transm Infect. 2008;84:318–323
  38. Lenselink CH, Gerrits MM, Melchers WJ, et al. Parental acceptance of human papillomavirus vaccines. Eur J Obstet Gynecol Reprod Biol. 2008;137:103–107
  39. Slomovitz BM, Sun CC, Frumovitz M, et al. Are women ready for the HPV vaccine?. Gynecol Oncol. 2006;103:151–154
  40. Cook JV, Dickinson HO, Eccles MP. Response rates in postal surveys of healthcare professionals between 1996 and 2005: An observational study. BMC Health Serv Res. 2009;9:160

PII: S1054-139X(10)00142-4

doi: 10.1016/j.jadohealth.2010.03.003

Journal of Adolescent Health
Volume 47, Issue 1 , Pages 3-11 , July 2010